|
Feb 12
|
Q4 2024 SAGE Therapeutics Inc Earnings Call
|
|
Feb 12
|
Biogen expects 2025 profit decline despite strong Q4
|
|
Feb 12
|
Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
|
|
Feb 12
|
Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Feb 12
|
Biogen Inc. (BIIB) Q4 Earnings and Revenues Surpass Estimates
|
|
Jan 4
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
|
|
Jan 2
|
Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs?
|
|
Jan 2
|
Piper Sandler downgrades Biogen, slashes PT by $177 amid transition challenges
|
|
Jan 1
|
Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term
|
|
Jan 1
|
The 5 worst performing stocks on the Nasdaq 100 in 2024
|